Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.
about
FOXP3 ensembles in T-cell regulationAdoptive immunotherapy for cancer: building on successImmune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Marked differences in human melanoma antigen-specific T cell responsiveness after vaccination using a functional microarray.Melanoma: oncogenic drivers and the immune systemImmune cell promotion of metastasisCancer immunotherapyThe ever-expanding role of HIF in tumour and stromal biologyEpirubicin, Identified Using a Novel Luciferase Reporter Assay for Foxp3 Inhibitors, Inhibits Regulatory T Cell ActivityStrategies and challenges in eliciting immunity to melanoma.Delayed functional maturation of natural regulatory T cells in the medulla of postnatal thymus: role of TSLP.Inability to mediate prolonged reduction of regulatory T Cells after transfer of autologous CD25-depleted PBMC and interleukin-2 after lymphodepleting chemotherapyDown-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma.Administration of a CD25-directed immunotoxin, LMB-2, to patients with metastatic melanoma induces a selective partial reduction in regulatory T cells in vivo.Fludarabine modulates immune response and extends in vivo survival of adoptively transferred CD8 T cells in patients with metastatic melanoma.Simultaneous Foxp3 and IDO expression is associated with sentinel lymph node metastases in breast cancerAdenovirus-mediated CD40L gene transfer increases Teffector/Tregulatory cell ratio and upregulates death receptors in metastatic melanoma patients.Infiltrative T regulatory cells in enucleated uveal melanomas.The role of regulatory T cells in cancer.Immune phenotype predicts risk for posttransplantation squamous cell carcinoma.Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma.Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanomaIntraepithelial effector (CD3+)/regulatory (FoxP3+) T-cell ratio predicts a clinical outcome of human colon carcinomaActivation of anti-tumor immune response and reduction of regulatory T cells with Mycobacterium indicus pranii (MIP) therapy in tumor bearing mice.PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer.Cell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticles.Phase II trial of the regulatory T cell-depleting agent, denileukin diftitox, in patients with unresectable stage IV melanoma.Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanomaRegulatory T cell frequency in patients with melanoma with different disease stage and course, and modulating effects of high-dose interferon-alpha 2b treatmentFOXP3 expression accurately defines the population of intratumoral regulatory T cells that selectively accumulate in metastatic melanoma lesionsCirculating Type-1 Anti-Tumor CD4(+) T Cells are Preferentially Pro-Apoptotic in Cancer Patients.CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cellsTumor-infiltrating CD8+ and FOXP3+ lymphocytes in triple-negative breast cancer: its correlation with pathological complete response to neoadjuvant chemotherapy.Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patientsImmunologic targeting of FOXP3 in inflammatory breast cancer cells.In vivo 6-thioguanine-resistant T cells from melanoma patients have public TCR and share TCR beta amino acid sequences with melanoma-reactive T cellsExpression of Foxp3 in colorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancerTelomere length in relation to immunological parameters in patients with renal cell carcinomaIPEX, FOXP3 and regulatory T-cells: a model for autoimmunity.Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.
P2860
Q24299602-20B1DEA9-28A9-4F3E-A310-BC8BC1F9DAC8Q24546258-13CB6F73-7A45-466C-B98F-9EA5A38A4687Q24596171-9B9F8097-061E-46F7-AA05-688A0FFC9197Q24815128-B9CF8193-0841-4F17-9540-DBC953C2E41EQ26775598-CBD7C4F2-E930-4362-99B5-DEA8369374D4Q26991724-F3F89B49-0F63-4AE9-9466-296B3B6A9634Q27026870-3CF5509F-2C8C-4CD0-96E9-5CD647DD297CQ28079015-20B27841-9036-4686-8E4B-3136ADB3C469Q28550203-FED8354E-2155-41A6-84D9-42FBDF1F3228Q30435893-312D4FC6-7A3F-4502-8815-4FF9EC649382Q33238306-65F7266C-F92C-43F7-B332-FC9F29434E89Q33282703-F7335921-1758-4268-BEA9-EA8F8598C7AAQ33284046-0CF2D28F-197D-4C18-B7AD-3AC511A22D9DQ33299427-AE360DC7-0351-407F-9802-61599ECEAA12Q33416009-E219C826-8953-4ECA-BFBD-D2DFC2864461Q33482453-CB8373D0-CFD0-4AC7-846E-707C4175C615Q33587584-B01E1AA0-DD44-406F-B325-1D3ABDD7FC81Q33623491-BFDCA85D-F162-4D21-91CB-79D00C8B3F55Q33631986-185C9645-E219-4DDB-84D7-5091338A17A3Q33748547-6A584A24-A592-4F01-A6E5-64666CFC787FQ33774580-EE6558F0-C657-46F9-A453-B7F96FAF6343Q33840446-DA5AC534-C887-46FF-AAA3-18197649C997Q33865610-9A938FB9-3356-496F-8E43-878425FDD2F5Q34044931-B6805BF2-1049-46A0-9A2D-E0D71D67FC71Q34073958-7838BA79-1117-4D70-8F84-D1E2F5A0CA86Q34079604-4ADD9A12-3DD3-4867-8075-D464132BCE2CQ34099760-56045D83-C608-45C8-BAFE-5DA3C54DD878Q34111789-46F055EC-11CF-460C-BF81-2F457E065EFCQ34114136-B3BF4C24-2287-4DC6-A41B-05A4705579B5Q34197717-4A36CCE1-9A51-4770-92DB-4E61066B135FQ34259974-6C62D32F-5B44-4FFA-8264-F53393A831B5Q34355686-8B83E07F-14CD-4F9F-8909-5558021449B1Q34447829-6C51315D-ABC7-4276-8643-FDE70F7B2552Q34538321-3076ACF7-3BF8-41E8-BD9E-906B41EB999EQ34558393-73DF4025-BBE3-4DD6-8941-031D6AF0FF8CQ34560957-843BC624-CB57-4514-81FC-A3C8A7816C7AQ34575227-6ED4B301-5B75-42EC-9A37-105058A3A7D2Q34577167-793FBD8E-DD35-426A-8C4A-9B05C4C18B3AQ34583514-5E0425EC-A230-400F-AE02-2D405A73956FQ34610483-CA2390B5-2D71-4CFF-AEAD-F2262A0452DB
P2860
Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Foxp3 expressing CD4+CD25(high ...... ction of infiltrating T cells.
@en
type
label
Foxp3 expressing CD4+CD25(high ...... ction of infiltrating T cells.
@en
prefLabel
Foxp3 expressing CD4+CD25(high ...... ction of infiltrating T cells.
@en
P2093
P1476
Foxp3 expressing CD4+CD25(high ...... ction of infiltrating T cells.
@en
P2093
Fabrice Lemaître
Guy Gorochov
Hervé Bachelez
Laurent Ferradini
Louis Dubertret
Manuelle Viguier
Min-Sun Cho
Olivier Verola
Philippe Kourilsky
P304
P356
10.4049/JIMMUNOL.173.2.1444
P407
P577
2004-07-01T00:00:00Z